Eisai and Biogen present four-year data on Lecanemab at AAIC 2025
Long-term treatment with lecanemab shows slowed progression of early Alzheimer’s disease, according to data presented at the…
Recover your password.
A password will be e-mailed to you.
- Advertisement -
- Advertisement -
Recover your password.
A password will be e-mailed to you.